tegafur has been researched along with Mucositis in 5 studies
Mucositis: An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY).
Excerpt | Relevance | Reference |
---|---|---|
"The aim of this study was to evaluate systematically the efficacy and safety of oral uracil-tegafur (UFT) plus leucovorin (LV) compared with infusional fluorouracil (5-FU) plus LV for advanced colorectal cancer." | 8.87 | Oral uracil-tegafur plus leucovorin vs fluorouracil bolus plus leucovorin for advanced colorectal cancer: a meta-analysis of five randomized controlled trials. ( Bin, Q; Cao, Y; Gao, F; Li, J; Liao, C, 2011) |
"The aim of this study was to evaluate systematically the efficacy and safety of oral uracil-tegafur (UFT) plus leucovorin (LV) compared with infusional fluorouracil (5-FU) plus LV for advanced colorectal cancer." | 4.87 | Oral uracil-tegafur plus leucovorin vs fluorouracil bolus plus leucovorin for advanced colorectal cancer: a meta-analysis of five randomized controlled trials. ( Bin, Q; Cao, Y; Gao, F; Li, J; Liao, C, 2011) |
"We examined the completion rate, safety, and adverse events in patients with T2N0 glottic carcinoma who received chemoradiotherapy with S-1 (tegafur-gimeracil-oteracil potassium)." | 3.80 | Radiotherapy concurrent with S-1 and radiotherapy alone for T2N0 glottic carcinoma: a retrospective comparative study. ( Higashino, M; Ichihara, S; Kawata, R; Lee, K; Nishikawa, S; Uesugi, Y, 2014) |
"Chemoradiation based on S-1, a novel oral antitumor agent of fluorinated pyrimidines, is the treatment for T2N0 glottic carcinoma; however, the optimal scheduling and dosing have still not been established." | 2.72 | A phase I study of concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma. ( Inoue, T; Kiba, T; Murata, H; Nagata, K; Nagata, M; Shimode, Y; Tomoda, K; Tsuji, H; Yamashita, T; Yukawa, H, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Higashino, M | 1 |
Kawata, R | 1 |
Lee, K | 1 |
Nishikawa, S | 1 |
Ichihara, S | 1 |
Uesugi, Y | 1 |
Sumiyoshi, M | 1 |
Suzuki, T | 1 |
Kimura, Y | 1 |
Bin, Q | 1 |
Li, J | 1 |
Liao, C | 1 |
Cao, Y | 1 |
Gao, F | 1 |
Chikama, T | 1 |
Takahashi, N | 1 |
Wakuta, M | 1 |
Nishida, T | 1 |
Tsuji, H | 1 |
Kiba, T | 1 |
Nagata, M | 1 |
Inoue, T | 1 |
Yukawa, H | 1 |
Yamashita, T | 1 |
Shimode, Y | 1 |
Murata, H | 1 |
Nagata, K | 1 |
Tomoda, K | 1 |
1 review available for tegafur and Mucositis
Article | Year |
---|---|
Oral uracil-tegafur plus leucovorin vs fluorouracil bolus plus leucovorin for advanced colorectal cancer: a meta-analysis of five randomized controlled trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Diarrhea; Fluorouracil; Humans | 2011 |
1 trial available for tegafur and Mucositis
Article | Year |
---|---|
A phase I study of concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma.
Topics: Adult; Aged; Dermatitis; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Drug Combi | 2006 |
3 other studies available for tegafur and Mucositis
Article | Year |
---|---|
Radiotherapy concurrent with S-1 and radiotherapy alone for T2N0 glottic carcinoma: a retrospective comparative study.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma; Chemoradiotherapy; Drug Combina | 2014 |
Protective effects of water-soluble low-molecular-weight beta-(1,3-1,6)d-glucan purified from Aureobasidium pullulans GM-NH-1A1 against UFT toxicity in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Basidiomycota; beta-Glucans; Cell Line, Tum | 2009 |
Noninvasive direct detection of ocular mucositis by in vivo confocal microscopy in patients treated with S-1.
Topics: Aged; Antineoplastic Agents; Drug Combinations; Eye Diseases; Female; Humans; Inflammation; Male; Mi | 2009 |